Home > Scientific Research > Paper Publications

Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

Hits:：

Institution:山东大学齐鲁医院
Title of Paper:Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
Journal:Frontiers in Immunology
First Author:徐谦
Document Code:EAED5C8F22B940DE9047C03F770F9225
Volume:12
Number of Words:8
Translation or Not:No
Date of Publication:2021-08
Release Time:2021-09-23

Pre One：What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis